Abstract Background: Pakistan’s healthcare system faces rising costs and inequitable access to medicines, with branded pharmaceuticals dominating prescriptions despite the availability of less expensive generics. Out-of-pocket medicine expenditure exceeds 60% of total health spending, placing an unsustainable burden on patients. Objective: To evaluate the prescription dynamics between branded and generic medicines in Pakistan, identify policy and regulatory gaps, and propose a strategic…